Question 1

What is the Trilogy System?

Accepted Answer

The Trilogy System is the only TAVR (transcatheter aortic valve replacement) solution for patients with severe aortic regurgitation. It is a dedicated system developed by JenaValve to address the needs of this patient population.

Question 2

What is the ALIGN-AR Study?

Accepted Answer

The ALIGN-AR study is a pivotal clinical trial evaluating the safety and efficacy of the TAVR procedure using the Trilogy System for patients with moderate-to-severe and severe aortic regurgitation who are at high risk for surgery.

Question 3

What is JenaValve's mission?

Accepted Answer

JenaValve is a global medical device company dedicated to supporting physicians and developing innovative medical device technology that addresses the needs of patients with structural heart disease.

Question 4

What are the key innovations in TAVR for aortic regurgitation?

Accepted Answer

The JenaValve Trilogy System and the ALIGN-AR study are pioneering a dedicated TAVR solution for aortic regurgitation, addressing the imaging challenges and real-world experience in the EU.

Question 5

Where can I find more information on the company and its products?

Accepted Answer

You can find more information about JenaValve, the Trilogy System, the ALIGN-AR study, and other videos and resources on the company's website.

Jenavalve Production Ltd

Company Overview

Company Name

Address

Website

Phone

Approx. Annual Revenue

Employees

About Jenavalve Production Ltd

Frequently Asked Questions about Jenavalve Production Ltd

What is the Trilogy System?

What is the ALIGN-AR Study?

What is JenaValve's mission?

What are the key innovations in TAVR for aortic regurgitation?

Where can I find more information on the company and its products?

Technologies Used

Key Decision Makers